Table of contents
Expand All Topics
Catheter-related thrombosis
Background
Overview
Definition
Central venous catheter thrombosis is a common complication of central venous catheter insertion characterized by thrombus formation around the site of the catheter.
1
Pathophysiology
Central venous catheter thrombosis is caused by activation of the coagulation cascade and formation of thrombin and clot associated with an indwelling catheter. Circulatory stasis, vascular endothelial injury, and hypercoagulable states predispose to the development of thrombus.
2
Disease course
Central venous catheter thrombosis may be asymptomatic or cause pain, swelling in the arm, shortness of breath, vena cava obstruction. Disease progression may lead to PE. Long-term sequelae may include postphlebitic syndrome.
2
Prognosis and risk of recurrence
The 28-day mortality rate in critically ill patients with central venous catheter thrombosis is estimated at 14.1%.
3
Guidelines
Key sources
The following summarized guidelines for the evaluation and management of catheter-related thrombosis are prepared by our editorial team based on guidelines from the European Society of Medical Oncology (ESMO 2023,2015), the International Initiative on Thrombosis and Cancer (ITAC 2022), the American Society of Hematology (ASH 2021), the European Society for Vascular Surgery (ESVS 2021), the Canadian Consensus Group on Cancer-Associated ...
Show more
Diagnostic investigations
Diagnostic imaging
As per CCG-CAT 2015 guidelines:
Obtain ultrasound in patients with suspected symptomatic catheter-related upper-extremity DVT.
B
Consider obtaining further diagnostic testing (such as contrast venography or CTV) in patients with negative ultrasound findings but with a high index of suspicion for catheter-related upper extremity DVT. Do not obtain serial ultrasound in this setting.
C
More topics in this section
D-dimer
Medical management
Anticoagulant therapy
As per ESMO 2023 guidelines:
Initiate anticoagulant therapy with LMWH, or alternatively VKAs or DOACs,
B
for a minimum of 3 months for the treatment of symptomatic catheter-related thromboses in patients with cancer. B
Consider extending anticoagulation until catheter removal if the bleeding risk is low in patients with CRT received 3 months of anticoagulant treatment.
C
More topics in this section
Thrombolysis